Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$93.97 -0.45 (-0.48%)
As of: Nov 11, 2026 · 9:39 AM EST

Mirum Pharmaceuticals (MIRM) Cash from Financing Activities (2019 - 2026)

Updated

Mirum Pharmaceuticals' Cash from Financing Activities was -$54.34 million in Q3 2026, compared with $16.1 million a year earlier.

Analysis

Mirum Pharmaceuticals (MIRM) Cash from Financing Activities (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Mirum Pharmaceuticals' Cash from Financing Activities was $436.17 million through Sep 30, 2026; for FY2025, it was $40.14 million, up 126.8% from FY2024.

  • Cash from Financing Activities shows a five-year compound annual growth rate of -26.0% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $17.7 million in FY2024 (-94.7%), $336.6 million in FY2023 (+208.6%), $109.09 million in FY2022 (+48.5%) and $73.47 million in FY2021 (-59.5%).
  • The Q3 2026 figure marks the lowest quarterly Cash from Financing Activities in data going back to Q2 2019.
  • The best year-over-year quarter for Cash from Financing Activities over five years was Q1 2025 (growth of 427.7%); the worst was Q4 2021 (a decline of 99.5%).
  • Per Business Quant data, MIRM's Cash from Financing Activities in the three quarters before Q3 2026 was $211.44 million (Q2 2026), $270.08 million (Q1 2026) and $9 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -7.22 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -8.53 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 6.82 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -2.43 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 6.63 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -4.39 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -1.53 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -2.51 Bn
10 Mirum Pharmaceuticals 6.16 Bn 4.58 Bn 150.55 Mn -54.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -54.34 Mn
Jun 30, 2026 211.44 Mn
Mar 31, 2026 270.08 Mn
Dec 31, 2025 9.00 Mn
Sep 30, 2025 16.10 Mn
Jun 30, 2025 8.69 Mn
Mar 31, 2025 6.36 Mn
Dec 31, 2024 5.34 Mn
Sep 30, 2024 3.86 Mn
Jun 30, 2024 7.29 Mn
Mar 31, 2024 1.21 Mn
Dec 31, 2023 1.78 Mn
Sep 30, 2023 207.13 Mn
Jun 30, 2023 114.71 Mn
Mar 31, 2023 12.99 Mn
Dec 31, 2022 -329,000.00
Sep 30, 2022 86.07 Mn
Jun 30, 2022 5.25 Mn
Mar 31, 2022 18.10 Mn
Dec 31, 2021 615,000.00
API Access

Mirum Pharmaceuticals Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MIRM&period=max&api_key=YOUR_API_KEY